Sodium vanadate combined with L-ascorbic acid delays disease progression, enhances motor performance, and ameliorates muscle atrophy and weakness in mice with spinal muscular atrophy.
about
Systemic administration of a recombinant AAV1 vector encoding IGF-1 improves disease manifestations in SMA miceSpinal muscular atrophy: an update on therapeutic progressHypothermia improves disease manifestations in SMA mice via SMN augmentation.Motor Neuron Gene Therapy: Lessons from Spinal Muscular Atrophy for Amyotrophic Lateral Sclerosis.
P2860
Sodium vanadate combined with L-ascorbic acid delays disease progression, enhances motor performance, and ameliorates muscle atrophy and weakness in mice with spinal muscular atrophy.
description
2013 nî lūn-bûn
@nan
2013 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Sodium vanadate combined with ...... with spinal muscular atrophy.
@ast
Sodium vanadate combined with ...... with spinal muscular atrophy.
@en
type
label
Sodium vanadate combined with ...... with spinal muscular atrophy.
@ast
Sodium vanadate combined with ...... with spinal muscular atrophy.
@en
prefLabel
Sodium vanadate combined with ...... with spinal muscular atrophy.
@ast
Sodium vanadate combined with ...... with spinal muscular atrophy.
@en
P2093
P2860
P356
P1433
P1476
Sodium vanadate combined with ...... e with spinal muscular atrophy
@en
P2093
Chen-Hung Ting
Hsin-Lan Wen
Hsiu-Mei Hsieh-Li
Huei-Chun Liu
Sue Lin-Chao
P2860
P2888
P356
10.1186/1741-7015-11-38
P407
P50
P577
2013-02-14T00:00:00Z
P5875
P6179
1000715371